MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/icvts/ivaf186

Медицинская библиотека · Interdisciplinary cardiovascular and thoracic surgery · 2025

Early Haemodynamic Performance and Clinical Outcomes of a Novel Bioprosthetic Mitral Valve.

Wada Yuki, Marui Akira, Nagasawa Atsushi, Tsumaru Shinichi, Hakamada Keisuke, Terazono Kazuya, Kitagata Yuta, Mihara Hironori, Ohno Nobuhisa

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

The MITRIS RESILIA mitral bioprosthesis is a novel pericardial valve developed to improve durability and haemodynamic performance. However, clinical data on its use in mitral valve replacement are limited. This single-center retrospective study aimed to evaluate the early haemodynamic performance and clinical outcomes of the MITRIS RESILIA valve in patients requiring mitral valve replacement.

METHODS

We retrospectively reviewed data from 66 patients who underwent mitral valve replacement using MITRIS RESILIA between May 2021 and May 2024. Transthoracic echocardiography was used to assess valve haemodynamic performance at discharge, 1 year, and 2 years postoperatively. The primary end-point was early valve haemodynamics, and the secondary end-points were overall survival and structural valve deterioration.

RESULTS

The mean age of the cohort was 75.0 ± 5.8 years, and 48.5% of the patients were male. The mean pressure gradient was 3.9 ± 1.4 mmHg at discharge, 4.0 ± 2.0 mmHg at 1 year, and 3.9 ± 1.3 mmHg at 2 years. The effective orifice area was 1.52 ± 0.50 cm2 after surgery. None of the patients experienced structural valve deterioration or significant paravalvular leak. The rate of freedom from all-cause mortality at 2 years was 93.3%.

CONCLUSIONS

MITRIS RESILIA demonstrated stable early haemodynamic performance across all valve sizes, including the 23 mm prosthesis. No cases of structural valve deterioration or paravalvular leak were observed, supporting its feasibility for mitral valve replacement. Further studies with extended follow-up are required to confirm the long-term durability and clinical benefits of the valve.

Для цитирования: Wada Yuki, Marui Akira, Nagasawa Atsushi, Tsumaru Shinichi, Hakamada Keisuke, Terazono Kazuya, Kitagata Yuta, Mihara Hironori, Ohno Nobuhisa. Early Haemodynamic Performance and Clinical Outcomes of a Novel Bioprosthetic Mitral Valve.. Interdisciplinary cardiovascular and thoracic surgery. 2025. DOI: 10.1093/icvts/ivaf186.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.